Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pan American Laboratories was a specialty pharmaceutical company based in Covington, Louisiana, that focused on the pediatric and primary care markets. The company specialized in the commercialization of branded prescription products, particularly in the respiratory and anti-infective therapeutic areas. Its portfolio featured products such as the antibiotic Cedax (ceftibuten) and several cough and cold treatments. In March 2010, Pan American Laboratories was acquired by Pernix Therapeutics for approximately $26 million in a combination of cash and stock. This acquisition significantly expanded Pernix's sales force and product offerings in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pan American Laboratories.